Relief from within: a peptide therapy for fibrosis.
Level V
Where this comes from
- Record sourced from PubMed, PMID 22649088.
- Also identified by DOI 10.1126/scitranslmed.3004138.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A modified, natural peptide derived from the antiangiogenic molecule endostatin has the potential to become a breakthrough therapy for organ fibrosis (Yamaguchi et al., this issue).
Medical subject headings
- Angiogenesis Inhibitors
- Endostatins
- Fibrosis
- Peptides